Patch-Wearable Cardioverter-Defibrillator Safe and Effective
By Lori Solomon HealthDay Reporter
FRIDAY, Aug. 2, 2024 -- A novel, water-resistant patch-wearable cardioverter-defibrillator (P-WCD) is safe and effective for patients at risk for sudden cardiac arrest, according to a study published in the Aug. 6 issue of the Journal of the American College of Cardiology.
John Hummel, M.D., from The Ohio State University in Columbus, and colleagues assessed the safety and clinical effectiveness of a novel P-WCD. The analysis included 290 patients at risk for sudden cardiac arrest due to ventricular tachycardia/ventricular fibrillation who were not candidates for or refused an implantable defibrillator.
The researchers found that the clinically significant cutaneous adverse device effect rate was 2.30 percent, with no severe adverse effects. There were no device-related deaths or serious adverse events reported. The inappropriate shock rate was 0.36 per 100 patient-months. Nine patients received 11 shocks, of which nine shocks were adjudicated to be appropriate. Eight of nine appropriate shocks were successful with a single shock. Median wear time compliance was 23.5 hours per day.
"There were no patient deaths or missed episodes requiring external rescue, and high patient compliance enabled a high number of successful life-saving conversions," the authors write.
Several authors disclosed ties to medical device companies, including Element Science, which manufactures the studied P-WCD and funded the trial.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
Women More Likely to Experience Anxiety, Depression After Out-of-Hospital Cardiac Arrest
THURSDAY, July 18, 2024 -- Out-of-hospital cardiac arrest (OHCA) survivors could experience changes in employment and income, and women may have an increase in dispensing of...
Education, Simulation Training Prepares Staff for Emergency Resternotomy
THURSDAY, June 6, 2024 -- Education and simulation training can improve staff comfort and familiarity with emergency resternotomy in the intensive care unit due to cardiac arrest...
Arrythmias Are a Significant Comorbidity in Adult Congenital Heart Disease
WEDNESDAY, April 17, 2024 -- For patients with adult congenital heart disease, arrythmias are a significant comorbidity and are associated with health care use and increased...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.